An ethno-epidemiological study to advance HIV prevention and treatment for PWUD

Information

  • Research Project
  • 10380515
  • ApplicationId
    10380515
  • Core Project Number
    R01DA043408
  • Full Project Number
    3R01DA043408-05S1
  • Serial Number
    043408
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    5/1/2017 - 8 years ago
  • Project End Date
    4/30/2022 - 3 years ago
  • Program Officer Name
    JENKINS, RICHARD A
  • Budget Start Date
    5/1/2021 - 4 years ago
  • Budget End Date
    4/30/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
    S1
  • Award Notice Date
    5/27/2021 - 4 years ago
Organizations

An ethno-epidemiological study to advance HIV prevention and treatment for PWUD

PROJECT SUMMARY/ABSTRACT Amidst disruptions stemming from the COVID-19 pandemic, including service interruptions and public health emphasis on stay-at-home orders, PWUD living with HIV may experience increased risk of suboptimal HIV treatment access and adherence outcomes. We are requesting an administrative supplement to examine the impact of COVID-19-related disruptions on PWUD living with HIV, focusing on treatment access and adherence, and organizational-level responses to the management of COVID-related risk. We propose to undertake this work in Vancouver, Canada, which is an ideal setting for the proposed research as it is characterized by: 1) a large population of PWUD living with HIV; 2) comprehensive and innovative HIV prevention and treatment interventions, which have also been implemented in other settings; and 3) ongoing National Institute on Drug Abuse (NIDA)-funded cohort studies of PWUD which facilitate our ethno- epidemiological research and ability to combine clinical and qualitative data. Building on our research infrastructure and experience studying HIV prevention and treatment among PWUD, we propose to examine the following aims: · AIM 1. To examine the impact of the COVID-19 pandemic, including public health measures such as stay-at-home orders and physical distancing, on co-management of HIV and other health conditions among PWUD living with HIV and complex comorbidities. · AIM 2. To identify systems-level barriers and facilitators to HIV treatment during the COVID-19 pandemic, including ART dispensation, particularly among people requiring HIV treatment assistance with complex comorbidities, and identify organizational adaptations made during the COVID-19 pandemic by HIV service organizations with comprehensive care models. 6

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    3
  • Direct Cost Amount
    99518
  • Indirect Cost Amount
    7961
  • Total Cost
    107479
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:107479\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    BSPH
  • Study Section Name
    Behavioral and Social Science Approaches to Preventing HIV/AIDS Study Section
  • Organization Name
    SIMON FRASER UNIVERSITY
  • Organization Department
  • Organization DUNS
    208032946
  • Organization City
    BURNABY
  • Organization State
    BC
  • Organization Country
    CANADA
  • Organization Zip Code
    V5A 1S6
  • Organization District
    CANADA